Pre-Clinical Toxicity: Avoiding Common Mistakes in Early Development



Pharma IQ
06/21/2010

Dr. Mitchell Friedman, Director of Toxicology at Takeda Pharmaceuticals, discusses pre-clinical toxicity and avoiding common mistakes in early development so as to secure patient safety and better ROI.
TO READ THE FULL STORY